{"id":1608,"date":"2018-05-31T22:40:39","date_gmt":"2018-05-31T22:40:39","guid":{"rendered":"http:\/\/neuroeconomix.com\/?p=1608"},"modified":"2025-01-28T18:01:48","modified_gmt":"2025-01-28T23:01:48","slug":"10-trends-in-heor","status":"publish","type":"post","link":"https:\/\/neuroeconomix.com\/es\/10-trends-in-heor\/","title":{"rendered":"10 Trends in HEOR"},"content":{"rendered":"

[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb10 tendencias de Econom\u00eda de la salud e investigaci\u00f3n de resultados en salud\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1871″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″ css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text el_class=\u00bbreferencias\u00bb]Por: <\/strong>Diana Gonz\u00e1lez-Bravo<\/strong>
\nMD, Epidemi\u00f3logo
\nInvestigador MBE
\nNeuroeconomix[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1863″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″ css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text el_class=\u00bbreferencias\u00bb]By: <\/strong> Diego Rosselli<\/strong>
\nMD. MSc. EdM
\nDirector General
\nNeuroEconomix[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

La Econom\u00eda de la salud e investigaci\u00f3n de resultados (HEOR por sus siglas en ingl\u00e9s) ha tomado fuerza y protagonismo en la medida que el gobierno y otros actores en la toma de decisiones en los sistemas de salud, consideran c\u00f3mo proporcionar los mejores resultados posibles, a costos asequibles. La Sociedad Internacional para Farmacoeconom\u00eda y desenlaces en salud (ISPOR por sus siglas en ingl\u00e9s) es la sociedad global l\u00edder en el campo, emiti\u00f3 un bolet\u00edn en el cual identific\u00f3 las tendencias de mayor impacto denominado \u201c2018 Top 10 HEOR Trends\u201d. A continuaci\u00f3n, la apreciaci\u00f3n del Dr. Diego Rosselli acerca de las tendencias en Econom\u00eda de la salud.<\/strong><\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]\"\"<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

El auge de la econom\u00eda de la salud es un fen\u00f3meno global. Todos los gobiernos del mundo, al igual que los aseguradores, los prestadores, la industria farmac\u00e9utica y de dispositivos m\u00e9dicos, y los usuarios de los sistemas de salud (que en \u00faltimas somos todos) estamos enfrentados a unos costos crecientes y a unas necesidades que, tambi\u00e9n, van aumentando. Es por eso muy oportuno el documento que acaba de producir ISPOR con el atractivo t\u00edtulo de \u201cTop 10 HEOR Trends\u201d, las diez tendencias actuales en econom\u00eda de la salud e investigaci\u00f3n de resultados. Valdr\u00eda la pena, para darle a\u00fan m\u00e1s credibilidad al documento, resaltar la metodolog\u00eda consensuada y participativa que le dio origen (obviamente con participaci\u00f3n colombiana).<\/p>\n

Algunas de estas \u201c10 tendencias\u201d las hemos vivido de cerca en Colombia en los \u00faltimos a\u00f1os. Entre ellas, las estrategias para regular los precios crecientes de muchos medicamentos innovadores, con mecanismos como las compras centralizadas o la regulaci\u00f3n de precios. La definici\u00f3n clara de c\u00f3mo aceptar o no el creciente auge de biosimilares es otro debate que aqu\u00ed se ha dado en varios \u00e1mbitos. La cobertura universal, que est\u00e1 lejos de ser una realidad en muchos pa\u00edses de la regi\u00f3n, es un tema en el que tambi\u00e9n marcamos una ventaja. Es vergonzoso ver c\u00f3mo Estados Unidos sigue muy atr\u00e1s en este indicador de equidad y, en \u00faltimas de verdadero desarrollo social. Tal vez no estemos tan preparados, en toda Am\u00e9rica Latina, como en el Viejo Continente, para el cambio demogr\u00e1fico que se nos avecina, con una poblaci\u00f3n que envejece a un ritmo mayor al que vivieron primero los pa\u00edses desarrollados. Nuestros hospitales, nuestro sistema de salud, y nuestras rutas de atenci\u00f3n han tenido que hacer un r\u00e1pido viraje para adaptarse a las necesidades que imponen las enfermedades cr\u00f3nicas no transmisibles. Es para all\u00e1 que va la epidemiolog\u00eda.<\/p>\n

En fin, la nueva salud p\u00fablica impone unos paradigmas diferentes, para intervenir sobre los estilos de vida, para empoderar a las comunidades para que as\u00ed los ciudadanos mismos asuman los nuevos retos, mucho de ellos en la prevenci\u00f3n y ya no en la terap\u00e9utica.<\/p>\n

Con este abrebocas, solo espero que consulten este interesante documento, para que reflexionen, cada quien desde su esquina, para que se pregunten a m\u00ed qu\u00e9 me corresponde hacer en este nuevo modo de ver la realidad de la salud, en su definici\u00f3n cada vez m\u00e1s amplia.<\/p>\n

El documento completo lo pueden consultar\u00a0AQU\u00cd<\/a><\/strong><\/em><\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=\u00bb.vc_custom_1533834464911{background-color: #f7f7f7 !important;}\u00bb][vc_column][vc_custom_heading text=\u00bbReferencias\u00bb font_container=\u00bbtag:h4|text_align:left|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_column_text el_class=\u00bbreferencias\u00bb]ISPOR 2018. Top 10 HEOR trends. Disponible en\u00a0www.ispor.org<\/a>.[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb10 Trends in HEOR\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1871″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″ css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text el_class=\u00bbreferencias\u00bb]Por: <\/strong>Diana Gonz\u00e1lez-Bravo<\/strong>
\nMD, Epidemi\u00f3logo
\nInvestigador MBE
\nNeuroeconomix[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1863″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″ css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text el_class=\u00bbreferencias\u00bb]By: <\/strong> Diego Rosselli<\/strong>
\nMD. MSc. EdM
\nDirector General
\nNeuroEconomix[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

The Health Economics and Results Research (HEOR) has gained power and distinction among government and other stakeholders in health system decision-making, those who consider how to provide the best possible results in health and health economics, at an affordable costs. ISPOR (International Society for Pharmacoeconomics and Health Outcomes) is the leading global society in the field, issued a newsletter in which identified the trends of greatest impact called \u00ab2018 Top 10 HEOR Trends\u00bb.<\/h4>\n

Afterwards, you can find Diego Rosselli\u2019s appreciation about the trends in Health Economics.<\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

\"\"<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

The boom of health economics is a global phenomenon. Government, insurers, providers, the pharmaceutical\/ medical device industry and the users of the health systems (which in the end are all of us) all over the world faced increasing costs and needs in health. This is the reason why the document that has just produced ISPOR with the attractive title of \u00abTop 10 HEOR Trends\u00bb, the ten current trends in health economics and results research is very timely. It would be worth it, to give the document even more credibility, to highlight the consensus and participatory methodology that gave rise to it (obviously with Colombian participation).<\/p>\n

Some of these \u00ab10 trends\u00bb we have been experienced closely in Colombia in recent years. Among them, strategies to regulate the rising prices of many innovative medicines, with mechanisms such as centralized procurement of drugs or price regulation. The clear definition of how to accept or not the growing biosimilar boom is another debate that has taken place here in several areas. Universal coverage in health, which is far from being a reality in many countries of the Latinamerican region, is an issue in which we also have an advantage. It is shameful to see how the United States is far behind in this indicator of equity and, ultimately, of true social development. We may not be as prepared (speaking of Latinamerica) as in the Old Continent, for the demographic change that is coming, with a population that ages at a rate greater than that experienced by developed countries first. Our hospitals, our health system, and our care routes have had to make a quick turnaround to adapt to the needs imposed by chronic non-communicable diseases. It is for there that epidemiology goes.<\/p>\n

Briefly, the new public health policies imposes different paradigms, to influence on lifestyles, to empower communities so that citizens themselves can assume new challenges, many of them in prevention and no longer in therapy.<\/p>\n

With this starter, I only hope that you consult this interesting document, so that you reflect, each one from your corner, so that you ask me what I have to do in this new way of seeing the reality of health, in its definition will amplified and become wider.<\/p>\n

The complete document can be found here<\/a><\/strong><\/em><\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=\u00bb.vc_custom_1533834464911{background-color: #f7f7f7 !important;}\u00bb][vc_column][vc_custom_heading text=\u00bbBibliography\u00bb font_container=\u00bbtag:h4|text_align:left|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_column_text el_class=\u00bbreferencias\u00bb]ISPOR 2018. Top 10 HEOR trends. Available at www.ispor.org<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb10 tendencias de Econom\u00eda de la salud e investigaci\u00f3n de resultados en salud\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1871″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″…<\/p>\n","protected":false},"author":19,"featured_media":2036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[4,8],"tags":[133,127,111,95,134],"ppma_author":[740],"class_list":["post-1608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-sistema-de-salud","tag-health-decision-making","tag-health-economics","tag-heor","tag-ispor","tag-trends"],"taxonomy_info":{"category":[{"value":4,"label":"Blogs Publicados"},{"value":8,"label":"Sistema de Salud"}],"post_tag":[{"value":133,"label":"health decision making"},{"value":127,"label":"health economics"},{"value":111,"label":"HEOR"},{"value":95,"label":"ISPOR"},{"value":134,"label":"trends"}]},"featured_image_src_large":["https:\/\/neuroeconomix.com\/wp-content\/uploads\/2018\/05\/toptrend-english-1.jpg",960,720,false],"author_info":{"display_name":"NeuroEconomix","author_link":"https:\/\/neuroeconomix.com\/es\/author\/wpnotifs\/"},"comment_info":0,"category_info":[{"term_id":4,"name":"Blogs Publicados","slug":"blog","term_group":0,"term_taxonomy_id":4,"taxonomy":"category","description":"","parent":0,"count":253,"filter":"raw","cat_ID":4,"category_count":253,"category_description":"","cat_name":"Blogs Publicados","category_nicename":"blog","category_parent":0},{"term_id":8,"name":"Sistema de Salud","slug":"sistema-de-salud","term_group":0,"term_taxonomy_id":8,"taxonomy":"category","description":"","parent":0,"count":156,"filter":"raw","cat_ID":8,"category_count":156,"category_description":"","cat_name":"Sistema de Salud","category_nicename":"sistema-de-salud","category_parent":0}],"tag_info":[{"term_id":133,"name":"health decision making","slug":"health-decision-making","term_group":0,"term_taxonomy_id":133,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"},{"term_id":127,"name":"health economics","slug":"health-economics","term_group":0,"term_taxonomy_id":127,"taxonomy":"post_tag","description":"","parent":0,"count":4,"filter":"raw"},{"term_id":111,"name":"HEOR","slug":"heor","term_group":0,"term_taxonomy_id":111,"taxonomy":"post_tag","description":"","parent":0,"count":3,"filter":"raw"},{"term_id":95,"name":"ISPOR","slug":"ispor","term_group":0,"term_taxonomy_id":95,"taxonomy":"post_tag","description":"","parent":0,"count":7,"filter":"raw"},{"term_id":134,"name":"trends","slug":"trends","term_group":0,"term_taxonomy_id":134,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"}],"authors":[{"term_id":740,"user_id":19,"is_guest":0,"slug":"wpnotifs","display_name":"NeuroEconomix","avatar_url":"https:\/\/neuroeconomix.com\/wp-content\/uploads\/2025\/01\/neuroeconomix-home-testimonials.svg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/1608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/comments?post=1608"}],"version-history":[{"count":1,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/1608\/revisions"}],"predecessor-version":[{"id":14426,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/1608\/revisions\/14426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media\/2036"}],"wp:attachment":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media?parent=1608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/categories?post=1608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/tags?post=1608"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/ppma_author?post=1608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}